University of Minnesota
240 Williamson Hall
231 Pillsbury Drive S.E.
About University of Minnesota
About the U of M
The University of Minnesota is one of the most comprehensive public universities in the United States and ranks among the most prestigious. It is both the state land-grant university, with a strong tradition of education and public service, and the state's primary research university, with faculty of national and international reputation.
The University of Minnesota's cutting-edge research and creation of new knowledge significantly contributes to world understanding and learning. As the state's primary research institution, the University receives 98 percent of all federally sponsored research grants awarded to higher education institutions in Minnesota.
The College of Biological Sciences at the University of Minnesota is one of few colleges nationwide devoted to biological sciences. CBS explores a world of opportunities, from molecules to ecosystems, to improve human health, develop renewable resources, enhance agriculture, and restore the environment.
Last Updated: 02-10-2006
207 articles with University of Minnesota
University of Minnesota & Partners Develop Winning Concept to Improve Patient Participation in Healthcare
A multidisciplinary team from the University of Minnesota is giving patients a more interactive role when making decisions about their care through a new award-winning app.
The University of Minnesota and the Medical Alley Association will host the US Department of Health & Human Services (HHS) for “Healthcare Startup Day Minnesota” on Monday, Oct. 15 at McNamara Alumni Center.
Groundbreaking science and technology come together to find potential answers for conditions such as muscular dystrophy
The AP in a recent report notes that drug price increases “slowed somewhat and were not quite as steep as in past years.” But overall, there has been no “massive” drug price cuts.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
University of Minnesota, University of Minnesota Physicians and Fairview Health Services announce expanded partnership to serve Minnesota families
Agreement creates academic health system focused on patient-centered care, innovation and clinical excellence
Hemophilia A patients have another treatment option. This morning the U.S. Food and Drug Administration gave the nod to Bayer AG’s new treatment, Jivi (BAY94-9027).
Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, today announced the appointment of Stanley Iyadurai, M.D., Ph.D. as Vice President of Clinical Development.
Masonic Cancer Center, University of Minnesota Receives 'Outstanding' Rating from the National Cancer Institute
The Masonic Cancer Center, University of Minnesota has received an overall rating of 'Outstanding' from the National Cancer Institute (NCI), as well as a renewal of its five-year Cancer Center Support Grant and reconfirmation of its comprehensive status.
University of Minnesota Medical School researchers gain new insight on "sunk cost fallacy," a cognitive phenomenon that looks at individuals committed to a choice, even when it is clear that there is a better alternative.
University of Minnesota School of Nursing Teams With GetWellNetwork to Bring Innovative Research to Commercial Health Care Market
Unique partnership will use mobile health technology to put congenital heart defect research into the hands of parents
Minnesota Governor Mark Dayton has declared April 26, 2018, "University of Minnesota Medical School Day," in recognition of the 130-year anniversary of its founding by the University Regents.
University of Minnesota Medical School researchers will conduct a first of its kind study to test the effect of the increase in minimum wage on health.
3M’s $26 million investment in the University’s Driven campaign, which spans a 10-year period, includes a new $8 million commitment to support scholarships and outreach programs.
Masonic Cancer Center, University of Minnesota Release: New Osteosarcoma Genetic Marker Could Tailor, Improve Treatment for Pediatric Patients
[01-November-2017] MINNEAPOLIS and ST. PAUL, Minn., Nov. 1, 2017 /PRNewswire/ -- Newly discovered genetic markers in osteosarcoma tumors could help tailor a more precise treatment, improving survival rates and quality of life for children and young adults with the disease. The study , recently published in Cancer Research , analyzed osteosarcoma tumor profiles from mice, dogs and hu
Masonic Cancer Center, University of Minnesota Awarded NCI CURE Grant To Mentor Future Cancer Researchers
Calyxt Launches U.S. Field Trials With University of Minnesota For Powdery Mildew-Resistant Spring Wheat Variety
Groundbreaking: University of Minnesota Research Shows People Can Control A Robotic Arm With Only Their Minds